Bulletin
Investor Alert

ALX Oncology Holdings Inc.

NAS: ALXO

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jun 24, 2022, 6:20 p.m.

/zigman2/quotes/219511930/composite

$

7.98

Change

-0.02 -0.25%

Volume

Volume 359,408

Quotes are delayed by 20 min

/zigman2/quotes/219511930/composite

Previous close

$ 7.45

$ 8.00

Change

+0.55 +7.38%

Day low

Day high

$7.26

$8.11

Open

52 week low

52 week high

$5.82

$81.19

Open

Annual Financials for ALX Oncology Holdings Inc.

Operating Activities

Fiscal year is January-December. All values USD millions. 2018201920202021 5-year trend
Net Income before Extraordinaries -(13.73M)(19.24M)(45.74M)(83.46M)
Depreciation, Depletion & Amortization -431,000429,000202,000736,000
Depreciation and Depletion -431,000429,000202,000736,000
Amortization of Intangible Assets -----
Deferred Taxes & Investment Tax Credit -----
Deferred Taxes -----
Investment Tax Credit -----
Other Funds -269,000308,0007M18.65M
Funds from Operations -(13.03M)(18.51M)(38.54M)(64.07M)
Extraordinaries -----
Changes in Working Capital -(159,000)4.26M247,000(4.03M)
Receivables -(932,000)396,000536,000-
Accounts Payable -(269,000)2.98M(3.74M)3.29M
Other Assets/Liabilities -1.03M751,000(1.53M)(10.62M)
Net Operating Cash Flow -(13.19M)(14.25M)(38.29M)(68.1M)

Investing Activities

2018201920202021 5-year trend
Capital Expenditures -(653,000)(353,000)(31,000)(666,000)
Capital Expenditures (Fixed Assets) -(653,000)(353,000)(31,000)(666,000)
Capital Expenditures (Other Assets) -----
Net Assets from Acquisitions -----
Sale of Fixed Assets & Businesses ---641,000-
Purchase/Sale of Investments -----
Purchase of Investments -----
Sale/Maturity of Investments -----
Other Uses ----(4.26M)
Other Sources -----
Net Investing Cash Flow -(653,000)(353,000)610,000(4.92M)

Financing Activities

2018201920202021 5-year trend
Cash Dividends Paid - Total -----
Common Dividends -----
Preferred Dividends -----
Change in Capital Stock -1,0002.61M469.39M2.75M
Repurchase of Common & Preferred Stk. -(6,000)---
Sale of Common & Preferred Stock -7,0002.61M469.39M2.75M
Proceeds from Stock Options -7,0002.61M469.09M202,000
Other Proceeds from Sale of Stock ---299,0002.55M
Issuance/Reduction of Debt, Net ---(6.51M)(281,000)
Change in Current Debt -----
Change in Long-Term Debt ---(6.51M)-
Issuance of Long-Term Debt -----
Reduction in Long-Term Debt ---(6.51M)(281,000)
Other Funds --12.75M--
Other Uses -----
Other Sources --12.75M--
Net Financing Cash Flow -1,00015.36M462.88M2.47M
Exchange Rate Effect -----
Miscellaneous Funds -----
Net Change in Cash -(13.84M)755,000425.2M(70.55M)
Free Cash Flow -(13.84M)(14.6M)(38.32M)(68.77M)
Link to MarketWatch's Slice.